吸入式一氧化氮輸送系統市場規模、佔有率和成長分析：按系統類型、應用、最終用戶、通路和地區分類－2026-2033年產業預測

2024 年全球吸入式一氧化氮輸送系統市場價值為 8.82 億美元，預計到 2025 年將成長至 9.6 億美元，到 2033 年將成長至 18.52 億美元，在預測期（2026-2033 年）內複合年成長率為 8.62%。

全球吸入式一氧化氮輸送系統市場的主要驅動力是臨床上對有效肺血管擴張療法的需求。這些療法能夠促進氧合，改善通氣/灌注失衡，尤其是在新生兒加護病房。該領域，包括氣體輸送系統、監測設備和一次性配件，在降低持續性肺動脈高壓和急性呼吸窘迫症候群等疾病的發病率和死亡率方面發揮著至關重要的作用。技術進步已使市場從傳統的散裝氣體系統轉向創新的攜帶式輸送平台。尤其是在新冠疫情期間，臨床應用的激增凸顯了高效能一氧化氮輸送的必要性，促使製造商開發具有自動化控制功能的緊湊型系統。此外，優惠的報銷政策和策略夥伴關係也正在加速各種醫療機構的採用。

全球吸入式一氧化氮輸送系統市場的成長要素

全球吸入式一氧化氮輸送系統市場的主要促進因素是呼吸系統疾病（例如急性呼吸窘迫症候群(ARDS) 和肺動脈高壓）的日益流行，這些疾病需要先進的治療性介入。吸入式一氧化氮在改善氧合和降低肺血管阻力方面的有效性日益受到認可，這推動了醫院和臨床機構的需求。此外，輸送系統的持續創新，以及對以患者為中心的護理和個人化醫療的日益重視，進一步加速了這些系統的應用。預計這一趨勢將改善患者預後並顯著推動市場成長。

全球吸入式一氧化氮輸送系統市場的限制因素

全球吸入式一氧化氮輸送系統市場的主要限制因素之一是醫療設備核准和使用方面嚴格的監管環境。冗長而複雜的監管核准流程會顯著延緩創新產品的上市。此外，高昂的合規成本以及大規模臨床試驗的需求也會阻礙中小企業進入市場。這種監管負擔，加上吸入式一氧化氮療法適應症範圍有限，限制了市場成長以及企業掌握各個治療領域新興機會的能力。

吸入式一氧化氮輸送系統的全球市場趨勢

全球吸入式一氧化氮輸送系統市場正呈現出顯著的趨勢，其臨床適應症正從傳統的新生兒護理領域拓展至更廣泛的領域。隨著臨床醫生探索圍手術全期應用和針對合併複雜疾病患者的標靶肺血管擴張等創新療法，這項技術在成人重症監護和各種肺部疾病領域正日益受到認可。這一轉變反映了跨學科合作的加強以及以個人化醫療為核心的臨床指南的演進。製造商正積極響應這一趨勢，拓展產品線以適應不同的臨床工作流程，並支持相關證據的積累，以證明這些系統在實際應用中的有效性，從而最佳化不同患者群體的治療方案。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球吸入式一氧化氮輸送系統市場規模：依系統類型分類

• 圓筒式輸送系統
• 發電機型系統

全球吸入式一氧化氮輸送系統市場規模：依應用領域分類

• 新生兒持續性肺動脈高壓（PPHN）
• 急性呼吸窘迫症候群（ARDS）
• 心臟外科手術

全球吸入式一氧化氮輸送系統市場規模：依最終用戶分類

• NICU
• ICU
• 心臟外科中心

全球吸入式一氧化氮輸送系統市場規模：按分銷管道分類

• 直銷
• 銷售代理

全球吸入式一氧化氮輸送系統市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Mallinckrodt Pharmaceuticals（INOmax）
• Bellerophon Therapeutics
• GeNO LLC
• Vero Biotech
• SensorMedics（CareFusion/BD）
• International Biomedical
• Air Liquide Medical Systems
• Linde plc
• Praxair（Linde）
• Air Products Healthcare
• BOC Healthcare（Linde）
• Messer Group
• NOxBOX（Advanced Inhalation Therapies）
• Advanced Inhalation Therapies
• Oxygen Biotherapeutics
• CIRCOR International
• Neodiagnostix
• Vapotherm Inc.
• Fisher & Paykel Healthcare
• Masimo Corporation

結論與建議

Global Inhaled Nitric Oxide Delivery Systems Market size was valued at USD 0.882 Billion in 2024 and is poised to grow from USD 0.96 Billion in 2025 to USD 1.852 Billion by 2033, growing at a CAGR of 8.62% during the forecast period (2026-2033).

The global inhaled nitric oxide delivery systems market is predominantly driven by the clinical need for effective pulmonary vasodilation therapies, which enhance oxygenation and address ventilation-perfusion mismatches, especially in neonatal intensive care. This sector, which includes gas delivery systems, monitoring devices, and disposable accessories, plays a crucial role in reducing morbidity and mortality rates associated with conditions like persistent pulmonary hypertension and acute respiratory distress syndrome. Technological advancements have transitioned the market from traditional bulk gas systems to innovative, portable delivery platforms. Notably, the surge in clinical applications during the COVID-19 pandemic underscored the need for efficient nitric oxide delivery, prompting manufacturers to develop compact systems with automated controls. Additionally, favorable reimbursement pathways and strategic partnerships have catalyzed wider adoption across various medical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhaled Nitric Oxide Delivery Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhaled Nitric Oxide Delivery Systems Market Segments Analysis

Global inhaled nitric oxide delivery systems market is segmented by system type, application, end-user, distribution and region. Based on system type, the market is segmented into Cylinder-Based Delivery Systems and Generator-Based Systems. Based on application, the market is segmented into Persistent Pulmonary Hypertension of the Newborn (PPHN), Acute Respiratory Distress Syndrome (ARDS) and Cardiac Surgery. Based on end-user, the market is segmented into NICUs, ICUs and Cardiac Surgical Centers. Based on distribution, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inhaled Nitric Oxide Delivery Systems Market

A key market driver for the Global Inhaled Nitric Oxide Delivery Systems market is the increasing prevalence of respiratory conditions, such as acute respiratory distress syndrome (ARDS) and pulmonary hypertension, which necessitate advanced therapeutic interventions. The growing recognition of inhaled nitric oxide's efficacy in improving oxygenation and reducing pulmonary vascular resistance has spurred demand in both hospital and clinical settings. Additionally, ongoing innovations in delivery systems, coupled with the rising focus on patient-centered care and personalized medicine, are further propelling the adoption of these systems. This trend is expected to enhance patient outcomes and drive market growth significantly.

Restraints in the Global Inhaled Nitric Oxide Delivery Systems Market

One key market restraint for the global inhaled nitric oxide delivery systems market is the strict regulatory landscape governing the approval and use of medical devices. The lengthy and complex regulatory approval processes can significantly delay the introduction of innovative products into the market. Additionally, the high costs associated with compliance and the need for extensive clinical trials can deter smaller companies from entering the market. This regulatory burden, coupled with the limited range of indications for inhaled nitric oxide therapy, restricts market growth and the ability to capitalize on emerging opportunities in various therapeutic areas.

Market Trends of the Global Inhaled Nitric Oxide Delivery Systems Market

The Global Inhaled Nitric Oxide Delivery Systems market is witnessing a significant trend towards the expansion of clinical indications beyond its established role in neonatal care. The technology is increasingly being recognized in adult critical care and a variety of pulmonary disorders, as clinicians explore innovative therapeutic applications such as perioperative uses and targeted pulmonary vasodilation for patients with complex comorbidities. This shift is indicative of greater interdisciplinary collaboration and evolving clinical guidelines focused on personalized medicine. Manufacturers are responding by enhancing their offerings to accommodate diverse clinical workflows and supporting evidence generation to demonstrate the real-world efficacy of these systems, thereby optimizing treatment pathways for varied patient populations.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Inhaled Nitric Oxide Delivery Systems Market Size by System Type & CAGR (2026-2033)

• Market Overview
• Cylinder-Based Delivery Systems
• Generator-Based Systems

Global Inhaled Nitric Oxide Delivery Systems Market Size by Application & CAGR (2026-2033)

• Market Overview
• Persistent Pulmonary Hypertension of the Newborn (PPHN)
• Acute Respiratory Distress Syndrome (ARDS)
• Cardiac Surgery

Global Inhaled Nitric Oxide Delivery Systems Market Size by End-User & CAGR (2026-2033)

• Market Overview
• NICUs
• ICUs
• Cardiac Surgical Centers

Global Inhaled Nitric Oxide Delivery Systems Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors

Global Inhaled Nitric Oxide Delivery Systems Market Size & CAGR (2026-2033)

• North America (System Type, Application, End-User, Distribution)
  • US
  • Canada
• Europe (System Type, Application, End-User, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (System Type, Application, End-User, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (System Type, Application, End-User, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (System Type, Application, End-User, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Mallinckrodt Pharmaceuticals (INOmax)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bellerophon Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeNO LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vero Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SensorMedics (CareFusion/BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Air Liquide Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linde plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Praxair (Linde)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Air Products Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Healthcare (Linde)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Messer Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOxBOX (Advanced Inhalation Therapies)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Inhalation Therapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxygen Biotherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIRCOR International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neodiagnostix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vapotherm Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations